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even in the stable post-MI 1-year survivors who received current state-
of-art therapeutics. Further larger studies are needed to deﬁne the
high-risk group in Korean stable post-MI survivors.
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BACKGROUND Current guidelines recommend appropriate revascu-
larization and optimal medical treatment (OMT) including antiplatelet
therapy, statin, beta-blocker, or renin-angiotensin system (RAS)
blocker in the treatment of acute myocardial infarction (AMI). The
purpose of this study is to describe the prescription status for OMT
and long-term clinical outcome according to the status for OMT at
discharge and at 1-year.
METHODS We consecutively enrolled AMI patients who underwent
percutaneous coronary intervention (PCI) in the COREA-AMI (CardiOvas-
cular Risk and idEntiﬁcAtion of potential high-risk population in AMI)
registry including nine major university hospitals throughout South Korea
from January 2004 to December 2009. OMTwas deﬁned as taking all three
medications including statin, beta-blocker, and RAS blocker (angiotensin
converting enzyme inhibitor or angiotensin receptor blocker) with dual
antiplatelet agent (DAPT) at discharge or with one or more antiplatelet
agent at 1 year. The primary endpoint was all-cause death and landmark
analysis for 1-year post-MI survivors were performed.
RESULTS Of 4,748 AMI patients, 2,517 were taking OMT with DAPT and
1,878 were not taking OMT at discharge. At 1 year, 1,719 were prescribed
OMT with one or more antiplatelet 1,845 were not prescribed OMT among
4,200whowere aliveat 1 year stablywithoutnon-fatalMIor stroke.Median
follow-up duration was 43.8 months (interquartile range 29.8 to 60.5
months).Within theﬁrst year, the incidence ratesofprimaryendpointwere
2.3% in OMT group and 5.4% in non-OMT group [Unadjusted HR (95%CI)
2.32 (1.69-3.19), p<0.001]. After 1 year from index PCI, all-cause deathwere
5.6% inOMTgroup and9.8% innon-OMTgroup [1.92 (1.43-2.59), p<0.001].
In multivariable Cox proportional hazards regression, non-OMT was inde-
pendent predictor for the primary endpointswithin the ﬁrst year [AdjustedHR 1.85 (1.34-2.57), p<0.001] and after 1 year from index AMI year [1.54
(1.14-2.09), p¼0.005]
CONCLUSIONS About 40% of post MI survivors were not prescribed
full OMT at the time of discharge or at 1 year. Long-term clinical
outcome was signiﬁcantly superior in the OMT group as compared
with non-OMT group not only within the ﬁrst year but also from 1 year
to study completion among stable post-MI 1 year survivors.
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BACKGROUND Clinical trials have failed to show a clear beneﬁt of
mechanical unloading of the left ventricle (LV) to limit ischemia-
reperfusion injury (IRI) in acute myocardial infarction (AMI), which
may reﬂect a poor understanding of whether to unload the LV before
or after reperfusion. We explored the kinetics of LV unloading with an
axial ﬂow catheter (Impella) in relation to balloon reperfusion as a
strategy to reduce infarct size and improve survival in AMI.
METHODS Weﬁrst employed a swinemodel of AMI. After 90minutes of
LAD occlusion, adult, male swine (n¼4.group) were randomized to
either: 1) 120 minutes of reperfusion alone (IRI), 2) 15, 30, or 60 minutes
of LV unloading before 120minutes of coronary reperfusion (Impella to
Balloon Group; ITB-15; ITB-30; ITB-60) or 3) 30 minutes of coronary
reperfusion followed by LV unloading and an additional 120 minutes of
reperfusion (Balloon to Impella Group; BTI-30). Infarct size,myocardial
kinase activity, and mitochondrial integrity were quantiﬁed. To begin
exploring the clinical utility of LV unloading before reperfusion we
retrospectively studied all patients in the USPella registry presenting
with acute ST-segment elevationmyocardial infarction and cardiogenic
shock who received an Impella within 120 minutes before (n¼41;
STEMI-ITB) or within 120 minutes after (n¼76; STEMI-BTI) percuta-
neous coronary reperfusion between 2009 and 2014.
RESULTS Compared to IRI alone, infarct size was reduced in the ITB-30
and ITB-60 groups, but not in the ITB-15 or BTI groups (Figure). Levels of
phosphorylated Akt, Erk-1/2, GSK3b and mitochondria per cardiomyocyte
were increasedwithin the infarct zone in the ITB-30and ITB-60groups, not
theBTI group. In the registry analysis, in-hospital (51%vs 28%,p¼0.02) and
30-day survival (42% vs 20%, p¼0.03) were higher in the STEMI-ITB than
the STEMI-BTI group.ASTEMI-ITB timeof less than60minutes (n¼38)was
associated with higher in-hospital survival than a STEMI-BTI time of less
than 60 minutes (n¼40) (50% vs 25%, p¼0.02).
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30 or 60 minutes before, not after, coronary reperfusion is associated
with reduced infarct size, increased cardioprotective signaling, and
improved mitochondrial integrity. These preclinical ﬁndings are
supported by improved survival among patients treated with an axial
ﬂow catheter before, not after reperfusion.
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BACKGROUND Routine thrombus aspiration is superior to conven-
tional primary percutaneous coronary intervention (PCI) in terms of
improved myocardial perfusion in patients with acute myocardial
infarction with ST-segment elevation (STEMI), but its clinical useful-
ness is still questionable. Myocardial perfusion after thrombus aspi-
ration has not been evaluated by a quantitative index of
microcirculatory resistance (IMR) in a randomized fashion.
METHODS We performed a randomized, controlled clinical trial to
evaluate impact of manual thrombus aspiration (the Eliminate aspi-
ration catheter, Terumo Medical Supply, Japan) on microcirculatory
resistance after primary PCI in 128 patients with the ﬁrst STEMI
randomly assigned to thrombus aspiration or conventional primary
PCI group before coronary angiography. The primary endpoint was
deﬁned as a mean value of IMRcorr in thrombus aspiration compared
to conventional PCI group. Myocardial perfusion grade, resolution of
ST-segment elevation, enzymatic infarct size, left ventricle remodel-
ing and rate of adverse cardiac events were secondary endpoints.
RESULTS Manual thrombus aspiration, as compared with conven-
tional PCI, resulted in signiﬁcantly lower IMR corr (27.516,8 U vs.
39,932,7 U, P ¼ 0,039). Treatment with thrombus aspiration, as
compared with conventional PCI, resulted in similar rates of
myocardial perfusion grade 0 or 1 (21,5% vs. 28,6%; RR 0,75; 95% CI,
0,41 to 1,38; P¼0,36), complete resolution of ST-segment elevation
(61,5% vs. 49,2%; RR 1,25; 95% CI, 0,91 to 1,71, P¼0,16), similar infarct
size (median AUC CK-MB: 4362 U/L (IQR: 696 to 15636 U/L) versus
4401 U/L (IQR: 996 to 15657 U/L), p¼0.27), similar median value of
WMSI (1,23 vs 1,23), LV sphericity volume index (0,43 vs. 0,41) and
similar rate of LV remodeling (27,9 vs 18,5%, p¼0,21). The rate of
major adverse events (death, myocardial infarction, stroke or hospi-
talization for heart failure) between the groups was similar 4,6% vs,
11,1%, P¼0,20. In a multiple regression model with the log-trans-
formed IMR as dependent variable, after adjusting for clinical,
angiographic and procedural variables, thrombus aspiration was not
an independent predictor of lower IMR (28.4 U; 95% CI, 24.7 to 32.8 U,
vs. 32.4 U; 95% CI, 28.1 to 37.4 U; estimate 0,877, 95%CI 0,715-1,077,
P¼0.21). Histopathological examination conﬁrmed successful
thrombus aspiration in 89.6% of patients.
CONCLUSIONS Manual thrombus aspiration reduces microcirculatory
resistance indicating better myocardial perfusion compared to con-
ventional PCI in patients with STEMI. However, routine manual
thrombus aspiration is not an independent predictor of reduced
microcirculatory resistance. Reduction in microcirculatory resistance
of 12,3% achieved by routine manual aspiration is not sufﬁcient to
allow echocardiographic or clinical improvement in STEMI patients at
mid-term follow up.
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BACKGROUND The composition of thrombus in infarct-related artery
is related to the age of thrombus. It has not been analyzed the impact
of thrombus age on the efﬁcacy of manual thrombus aspiration in
STEMI patients assessed by invasive and quantitative method of
measuring microcirculatory resistance.
METHODS Out of 128 patients randomly allocated to either routine
manual thrombus aspiration or standard pPCI, 75 patients underwent
thrombus aspiration of which 10 patients had crossover. The efﬁcacy
of thrombus aspiration was assessed by determining the index of
microcirculatory circulation. The age of thrombus was assessed after
hematoxylin eosin staining. Fresh thrombi were rich in erythrocytes
with no signs of lysis of nuclei. Lytic thrombi had signs of lysis and
cardiohexia, while organized thrombi had thick collagen bands.
RESULTS In 49 patients thrombus size allowed histologic examina-
tion with hematoxillin eosin staining. Fresh thrombus was found in 25
patients and lytic or organized thrombus was found in 24 patients.
There were no differences in baseline clinical characteristics between
the group with fresh and old thrombi: 59.710.55 vs. 57.913.07,
P¼0.6, 76.0 vs. 75.8% male patients, risk factors >2 44.0 vs 16.7%,
P¼0.06, patient delay median 45 (IQR 15-127,5) vs. 60 (IQR 28.75-
222.5) min, P¼0.17, total ischemic time 166 (IQR 131.25-302.5) vs. 202,5
(IQR140.0-333.75), P¼0.21, antecedent angina 56.0 vs. 50.0%, P¼0.88,
the rate of anterior STEMI 40.0 vs. 29.2%, P¼0.63 and total ST-
segment deviation 16.28.94 vs. 16.79.91, P¼0.85, respectively.
There were no inter-group differences in angiographic and procedural
characteristics: multi vessel disease (48.0 vs. 50.0%, P¼0.69), TIMI
0 or 1 at baseline (84 vs. 87.5%, P¼0.72), TIMI 3 after completion of
pPCI (96.0 vs 91.7%, P¼0.52), thrombus length (12.38.86 vs.
12.48.12, P¼1) and ﬁnal MBG 0 or 1 (20.0% vs. 33.3%, P¼0.29). Res-
olution of ST-segment elevation (80.0 vs. 50.0%, P¼0.027) and
IMRcorr (23.213.65 vs. 37.227.32, P¼0.032) were lower in the group
with fresh thrombi compared to old thrombi. There was a trend to-
wards lower rate of distal embolizations in the group with fresh
thrombi (8.0 vs. 22.9%, P¼0.074). However, there were no differences
in infarct size (AUC CK 41542.731052.9 vs. 44712.126186.1, P¼0.71),
LVEF (55.211.67 vs. 54.010.63, P¼0.72,) WMSI (1.370.37 vs.
1.290.32) or remodeling rate (28.0 vs. 25.0%, P¼1) between the
groups with fresh and old thrombi.
CONCLUSIONS The manual aspiration of fresh thrombi leads to
improvedmyocardial perfusion in STEMI patients as comparedwith old
thrombi. However, we were unable to identify clinical or angiographic
characteristics to be associated with fresh thrombi. In addition,
improved myocardial perfusion was not associated with improved
clinical outcome in patients with fresh compared to old thrombi.
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BACKGROUND Previous studies have suggested that thyroid
dysfunction is associated with the mortality in patients with acute
myocardial infarction, but whether the thyroid function status is
associated with the prognosis of primary PCI has not been evaluated
sufﬁciently.
METHODS Consecutive 1079 patients with ST-elevation myocardial
infarction (STEMI), who were hospitalized in Fuwai hospital from
January 2010 to December 2012, were enrolled into this study. All
patients underwent primary PCI treatment and thyroid function pro-
ﬁle evaluation within the ﬁrst 12 hours after admission. The duration
